Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRU-MATRIX: Customized P2Y12 Blocker Choice in ACS
NCT01477775Phase 4Unknown
- Sponsor
- GISE
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, prasugrel, ticagrelor in acute coronary syndrome (ACS), sponsored by GISE. Status: unknown.
02
Drugs
clopidogrelprasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01477775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01477775.